Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diclofop-Methyl SCHEMBL7581827 | 0.88 | FFAR1 (0.33) | FFAR1MAPTL3MBTL1SMN1; SMN2 | |
| Bifenox SCHEMBL7579080 | 0.83 | TDP1 (0.55) | FFAR1MAPTMEN1KMT2ALMNA | |
| Mecoprop SCHEMBL7575545 | 0.82 | TSHR (0.46) | MAPTMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5467830 | 0.81 | MAPT (0.37) | MAPTKMT2A | |
| SCHEMBL39177 | 0.81 | MAPT (0.37) | MAPTKMT2A | |
| Quizalofop SCHEMBL7583244 | 0.81 | TP53 (0.43) | MAPTL3MBTL1TP53LMNASMN1; SMN2 | |
| Fenoxaprop SCHEMBL7587939 | 0.81 | P2RX3 (0.35) | P2RX3 | |
| SCHEMBL7579043 | 0.81 | FFAR1 (0.32) | FFAR1SMN1; SMN2 | |
| Clodinafop SCHEMBL7583811 | 0.79 | L3MBTL1 (0.40) | L3MBTL1P2RX3 | |
| Propaquizafop SCHEMBL7581012 | 0.78 | TP53 (0.40) | MAPTL3MBTL1TP53LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | FFAR1 4198/4885MAPT 1092/4885MEN1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.